A*STAR
1 Fusionopolis Way
#20-10 Connexis North Tower
Singapore
138668
Tel: 65-6826-6111
Fax: 65-6777-1711
Website: http://www.research.a-star.edu.sg/
321 articles about A*STAR
-
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
10/3/2023
A*STAR’s Genome Institute of Singapore, NanoString® Technologies, Inc., and Next Level Genomics, announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response.
-
RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore
11/21/2022
RVAC Medicines Pte. Ltd., a messenger RNA technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research announced the signing of a master research collaboration agreement to jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.
-
WuXi Advanced Therapies and A*STAR announce partnership to advance cell and gene therapy in the Asia-Pacific region
4/28/2022
WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, and A*STAR's Bioprocessing Technology Institute, announced a new partnership to bring WuXi ATU's proprietary Tetracycline-Enabled Self-Silencing Adenovirus technology to the Asia-Pacific region.
-
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
1/27/2022
Agilent Technologies Inc. recently signed a Research Collaboration Agreement with the Singapore Institute of Food and Biotechnology Innovation outlining their collaboration on developing food research knowledge advancement over the next two years.
-
Scientists from different agencies and research facilities have turned to laboratory manufactured human mini-brains to study the onset and progression of Parkinson's disease.
-
Former Top A*STAR Scientists Launch Abasia, A Singapore-based Reagents Manufacturer, To Support Increased Testing Locally
6/1/2021
Reagents are critical raw materials in COVID-19 diagnostic kits. Local production secures Singapore’s goal to make testing part of the new normal, and mitigate disruptions from the international supply chain
-
Advanced Medtech Commercialises Industry-first SARS-CoV-2 Direct Multiplex RT-PCR Assay Co-developed By A*STAR and DSO
7/20/2020
RESOLUTE 2.0, an industry-first SARS-CoV-2 direct multiplex Reverse-Transcription Polymerase-Chain-Reaction assay kit co-developed by Singapore’s Agency for Science Technology and Research and DSO National Laboratories, has been made available for clinical use in Singapore by Advanced MedTech Holdings, a global medical technology leader.
-
Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus
6/16/2020
SAFER™ Sample Kit offers accessible, non-invasive, and safe sample collection via saliva to enable cost-effective mass testing;
-
Human Breast Milk Breakthrough by TurtleTree Labs
2/7/2020
TurtleTree Labs sets to showcase the world's first human breast milk using cell-based technology at their April 21, 2020 Future of Clean Milk launch.
-
Human Stem Cells And Cancer Origins Discovered In The Stomach For The First Time
2/6/2020
A single AQP5+ human gastric stem cell gives rise to a 3D gastric organoid that re-expresses AQP5.
-
Singapore Scientists Reveal a Metabolic Pathway as a New Target in Liver Cancer Treatment
1/7/2020
Study showed that two metabolic enzymes in the proline metabolic pathway are potential targets to inhibit cancer cell growth, and offers new hope for effective liver cancer treatments
-
A!maginostic Partners A*STAR’s Institute Of Molecular And Cell Biology To Establish A New Joint Lab Of Excellence For Smart Digital And Multiplex Pathology
11/25/2019
The collaboration will use Image Processing and Artificial Intelligence/Machine Learning to revolutionise pathology practice and provide more precise cancer diagnostic assays
-
Researchers Find Link Between Eye Disease And Degeneration Of The Brain
11/6/2019
A scientific study of African populations discovers that the beta-amyloid gene is associated with an increased risk of the most common form of glaucoma
-
Taking Better Aim at Nasopharyngeal Carcinoma Using Proton Therapy
11/5/2019
A*STAR’s Institute of Bioengineering and Nanotechnology has teamed up with the Singapore Institute of Advanced Medicine Holdings Pte Ltd to explore how to better tackle nasopharyngeal carcinoma, a type of head and neck cancer, through targeted proton therapy.
-
Trailblazing scientific talent receive Singapore’s highest research and innovation accolades
10/17/2019
Two teams and an individual have been awarded this year’s President’s Science and Technology Awards[1][1], the highest honours bestowed upon research scientists and engineers in Singapore whose work have resulted in significant scientific, technological or economic benefits for the country.
-
Singapore Scientists Discover New Ways To Treat Liver Cancer
9/26/2019
Studies on a novel protein that helps cancer cells to grow and spread may help in the development of more efficient therapies for liver cancer
-
New Gels Expected to Help in the Development of Anti-cancer Drugs
8/29/2019
Researchers from A*STAR’s Institute of Bioengineering and Nanotechnology have developed a customisable hydrogel that cultivates patient-derived tumour organoids which can better mimic the original.
-
Scientists Eye Novel Drug Candidate With Marine Origins To Treat Vision Loss
8/8/2019
Researchers from Singapore and the United States are focused on a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
-
Nanomedicines Based On Green Tea Used To Target Cancers
8/7/2019
Researchers from A*STAR’s Institute of Bioengineering and Nanotechnology have successfully developed an innovative nanocarrier derived from green tea catechins, which can deliver anti-cancer drugs in a targeted and effective fashion.
-
New Antibody Drug to Potentially Treat Cancer
8/1/2019
Singapore scientists and clinicians have discovered a promising use of antibodies to target a new cancer antigen, as an alternative for chemotherapy